Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial

PaperCitations, authors & open-access status

Vandetanib in patients with previously treated RET-rearranged advanced non-small-cell lung cancer (LURET): an open-label, multicentre phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 297 citations, 2016 year and closed oa status.

297
Citations
2016
Year
closed
OA Status

Related on ScholarIQ

Kiyotaka Yoh
Author
Genichiro Ishii
Author
Shingo Matsumoto
Author
Kōichi Goto
Author
The Lancet Respiratory Medicine
Journal
Lung Cancer Treatments and Mutations
Topic
470M+ articles · free account